Torti Frank
Insider CIK 1647805 · ABUS Director · ROIV President and Vant Chair · AXON Director · MYOV Director · UROV Director · IMVT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-09-30 | 2026-10-02 | 40,309 | $36.57 | $1.47M | 13,495,893 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-06-30 | 2026-07-02 | 40,310 | $35.39 | $1.43M | 13,536,202 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2026-04-07 | 2026-04-09 | 88,325 | — | $0 | 88,325 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2026-04-07 | 2026-04-09 | 174,189 | — | $0 | 1,009,228 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-03-31 | 2026-04-02 | 160,035 | $27.70 | $4.43M | 13,576,512 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-02-23 | 2026-02-23 | 587,390 | — | $0 | 3,026,184 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-02-23 | 2026-02-23 | 587,390 | $27.51 | $16.16M | 13,736,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-02-23 | 2026-02-23 | 587,390 | $3.85 | $2.26M | 14,323,937 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-02-20 | 2026-02-23 | 1,012,610 | — | $0 | 3,613,574 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-02-20 | 2026-02-23 | 1,012,610 | $27.15 | $27.49M | 13,736,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-02-20 | 2026-02-23 | 1,012,610 | $3.85 | $3.90M | 14,749,157 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-02-19 | 2026-02-23 | 1,400,000 | — | $0 | 4,626,184 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-02-19 | 2026-02-23 | 1,400,000 | $27.42 | $38.39M | 13,736,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-02-19 | 2026-02-23 | 1,400,000 | $3.85 | $5.39M | 15,136,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | G Gift | 2025-12-24 | 2025-12-29 | 110,489 | — | $0 | 13,736,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2025-12-24 | 2025-12-29 | 64,891 | $22.47 | $1.46M | 13,847,036 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2025-12-23 | 2025-12-29 | 175,380 | $22.45 | $3.94M | 13,911,927 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2025-07-30 | 2025-08-01 | 11,900,000 | — | $0 | 13,736,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2025-07-30 | 2025-08-01 | 1,836,547 | — | $0 | 1,836,547 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2025-04-01 | 2025-04-03 | 93,599 | — | $0 | 93,599 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2025-04-01 | 2025-04-03 | 199,365 | — | $0 | 835,039 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2024-05-23 | 2024-05-24 | 67,000 | — | $0 | 67,000 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2024-04-02 | 2024-04-04 | 50,167 | — | $0 | 50,167 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2024-04-02 | 2024-04-04 | 120,400 | — | $0 | 635,674 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2023-05-24 | 2023-05-26 | 55,000 | — | $0 | 55,000 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2023-04-12 | 2023-04-14 | 158,292 | — | $0 | 158,292 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2023-04-12 | 2023-04-14 | 121,916 | — | $0 | 515,274 | SEC↗ |
| IMVT Immunovant, Inc. | P Buy | 2022-09-29 | 2022-09-29 | 20,000 | $5.81 | $116.2K | 393,358 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2022-08-17 | 2022-08-19 | 339,296 | — | $0 | 339,296 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2022-08-17 | 2022-08-19 | 225,632 | — | $0 | 373,358 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2022-05-25 | 2022-05-26 | 41,000 | — | $0 | 41,000 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2022-01-10 | 2022-01-12 | 329,485 | — | $0 | 554,748 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2022-01-10 | 2022-01-12 | 100,126 | — | $0 | 147,726 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2021-06-03 | 2021-06-07 | 22,000 | — | $0 | 22,000 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | A Award deriv | 2021-04-15 | 2021-04-19 | 42,000 | — | $0 | 42,000 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2021-03-19 | 2021-03-23 | 28,900 | — | $0 | 28,900 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2021-03-19 | 2021-03-23 | 19,200 | — | $0 | 47,600 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2020-05-28 | 2020-06-01 | 22,000 | — | $0 | 22,000 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2020-05-15 | 2020-05-18 | 42,600 | — | $0 | 42,600 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2020-05-15 | 2020-05-18 | 28,400 | — | $0 | 28,400 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award deriv | 2020-04-15 | 2020-04-17 | 17,500 | — | $0 | 17,500 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2019-12-18 | 2019-12-20 | 11,488 | — | $0 | 11,488 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2019-12-18 | 2019-12-20 | 137,617 | — | $0 | 137,617 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2019-12-18 | 2019-12-20 | 893 | — | $0 | 893 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2019-12-18 | 2019-12-20 | 3,765 | — | $0 | 3,765 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2019-08-23 | 2019-08-27 | 58,608 | — | $0 | 58,608 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2019-08-17 | 2019-08-20 | 22,000 | — | $0 | 22,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award deriv | 2019-07-09 | 2019-07-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AXGT Axovant Sciences Ltd. | A Award deriv | 2019-04-15 | 2019-04-17 | 255,000 | — | $0 | 255,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2018-11-26 | 2018-11-27 | 44,000 | — | $0 | 44,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award deriv | 2018-11-21 | 2018-11-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2018-11-06 | 2018-11-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2018-10-15 | 2018-10-16 | 150,000 | — | $0 | 150,000 | SEC↗ |